Fondazione Per L'Istituto Oncologico di Ricerca (Ior)

Fondazione Per L'Istituto Oncologico di Ricerca (Ior) is a research organisation in Bellinzona, Switzerland that has taken part in 5 EU-funded projects since 2016, receiving €4.4M in EU funding and leading 2 as coordinator.

EU funding received€4.4M
EU projects5
As coordinator2
Running now3
First EU project2016
Latest project2026
CountrySwitzerland
EU registration (PIC)933168325
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Fondazione Per L'Istituto Oncologico di Ricerca (Ior)'s own share of each project, not the project's full budget.

  • Horizon 2020€3.9M · 2 projects
  • Horizon Europe€487k · 3 projects

Projects

5 EU-funded projects, newest first. Fondazione Per L'Istituto Oncologico di Ricerca (Ior) led 2 of them as coordinator. Each links to the official record.

  • PROPANTHERAPartner

    Retrograde atrophy induction: a paradigm shift in prostate and pancreatic cancer prevention and therapy.

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €487ktheir share
  • CarrerasPathfindersAssociated partner

    Enabling the next generation in search of blood cancer cures

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • CarrerasLeadersAssociated partner

    Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • CLLCLONECoordinator

    Harnessing clonal evolution in chronic lymphocytic leukemia

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €1.9Mtheir share
  • Immune-senescenceCoordinator

    Dual targeting of senescence and tumor immunity for cancer therapy

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €2.0Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • cell signaling
  • genomes
  • immunotherapy
  • leukemia
  • mutation
  • oncology
  • prostate cancer
  • proteomics
  • radio frequency
  • surgery

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime